Lower riskMedical device recall · FDA · Published March 13, 2019
MedComp 14F SLX Catheter Kits Have Wrong Introducer Type - Recall
MedComp recalls 14F SLX Double Lumen Hemodialysis catheter kits that contain non-valved introducers instead of valved ones, which could cause complications during dialysis.
“MedComp 14F SLX Catheter Kits Have Wrong Introducer Type - Recall.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/68841-medcomp-14f-slx-catheter-kits-have-wrong-introducer-type-recall. Based on FDA recall #Z-1149-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1149-2019%22&limit=1).
The FDA announced on March 13, 2019, that Medical Components, Inc dba MedComp voluntarily recalled 14F SLX Double Lumen Full Tray Hemodialysis catheter insertion kits due to a labeling error. The hazard involves the incorrect introducer type being included in the kits.
According to the FDA, the tray label indicates the kits are packaged with a 15F "valved" peelable introducer, but the kits contain a 15F "non-valved" peelable introducer.
Context
GovInfoNow's records show Medical Components, Inc dba MedComp has 7 other recalls on record since November 22, 2017. Other recent recalls of similar products include MedComp 15.SF X 24CM Titan HD Catheter Recall (July 27, 2020) and MedComp Power Injectable CT Port Kits Recalled (January 13, 2021). Additional similar product recalls include Medline Intubation Tray Recall (December 24, 2025) and Medline Medical Procedure Kits Recall (May 4, 2026).
How to tell if you have this one
Check for the item number MC061422 on the kit packaging. The kits were sold with specific model codes like MCAL680, MCBA840, and others listed in the recall notice.
Brand
MedComp
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Kit Packaging
Look for the item number MC061422 on the kit packaging to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed in 20 states.
Listed by the agency
Not listed
FDA distribution: “Distributed to accounts in CA FL GA IN KY LA MA MI MO MS NJ NY OH OK PA SC TN TX VA WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California, Florida, Georgia, Indiana, Kentucky, Louisiana, Massachusetts, Michigan, Mississippi, Missouri, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia.
Recall timeline
FDA terminated this recall 5 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1149-2019 (March 13, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1149-2019 to see it in context.
Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.